Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Eton Pharmaceutcials Inc (NQ: ETON ) 5.940 +0.030 (+0.51%) Streaming Delayed Price Updated: 4:00 PM EDT, Oct 2, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Price and Volume Detailed Quote Volume 56,372 Open 5.850 Bid (Size) 5.250 (1) Ask (Size) 5.940 (1) Prev. Close 5.910 Today's Range 5.810 - 6.110 52wk Range 3.030 - 6.250 Shares Outstanding 25,688,062 Dividend Yield N/A Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year Top News More News Eton Pharmaceuticals to Participate at the H.C. Wainwright 26th Annual Global Investment Conference August 22, 2024 From Eton Pharmaceuticals Via GlobeNewswire ETON Stock Earnings: Eton Pharmaceuticals Misses EPS, Misses Revenue for Q2 2024 August 08, 2024 ETON stock results show that Eton Pharmaceuticals missed analyst estimates for earnings per share and missed on revenue for the second quarter of 2024. Via InvestorPlace Performance YTD +29.41% +29.41% 1 Month +29.13% +29.13% 3 Month +81.10% +81.10% 6 Month +61.41% +61.41% 1 Year +49.25% +49.25% More News Read More Eton Pharmaceuticals Reports Second Quarter 2024 Financial Results August 08, 2024 From Eton Pharmaceuticals Via GlobeNewswire Eton Pharmaceuticals to Report Second Quarter 2024 Financial Results on Thursday, August 8, 2024 July 30, 2024 From Eton Pharmaceuticals Via GlobeNewswire Recap: Eton Pharmaceuticals Q4 Earnings March 14, 2024 Via Benzinga Eton Pharmaceuticals Earnings Preview March 13, 2024 Via Benzinga Is NASDAQ:ETON suited for growth investing? March 06, 2024 Via Chartmill SWK Holdings Highlights Recent Achievements and Provides Portfolio Update July 17, 2024 Via ACCESSWIRE Eton Pharmaceuticals Announces FDA Acceptance of New Drug Application for ET-400 (Hydrocortisone Oral Solution) July 15, 2024 From Eton Pharmaceuticals Via GlobeNewswire ETON Stock Earnings: Eton Pharmaceuticals Beats EPS, Misses Revenue for Q1 2024 May 09, 2024 Via InvestorPlace Eton Pharmaceuticals Reports First Quarter 2024 Financial Results May 09, 2024 From Eton Pharmaceuticals Via GlobeNewswire Why the growth investor may take a look at NASDAQ:ETON. February 14, 2024 Via Chartmill Evaluating NASDAQ:ETON for Growth Investment Opportunities. January 22, 2024 Via Chartmill Eton Pharmaceuticals: Q3 Earnings Insights November 09, 2023 Via Benzinga Eton Pharmaceuticals to Present at the Citizens JMP Life Sciences Conference May 01, 2024 From Eton Pharmaceuticals Via GlobeNewswire Eton Pharmaceuticals Announces Submission to FDA of New Drug Application for ET-400 (Hydrocortisone Oral Solution) April 30, 2024 From Eton Pharmaceuticals Via GlobeNewswire Eton Pharmaceuticals to Report First Quarter 2024 Financial Results on Thursday, May 9, 2024 April 29, 2024 From Eton Pharmaceuticals Via GlobeNewswire 12 Health Care Stocks Moving In Friday's Pre-Market Session March 22, 2024 Via Benzinga Eton Pharmaceuticals Announces Acquisition of PKU GOLIKE® for Phenylketonuria March 22, 2024 From Eton Pharmaceuticals Via GlobeNewswire ETON Stock Earnings: Eton Pharmaceuticals Misses EPS, Misses Revenue for Q4 2023 March 14, 2024 Via InvestorPlace Eton Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results March 14, 2024 From Eton Pharmaceuticals Via GlobeNewswire Eton Pharmaceuticals to Report Fourth Quarter and Full Year 2023 Financial Results on Thursday, March 14, 2024 February 29, 2024 From Eton Pharmaceuticals Via GlobeNewswire Earnings Scheduled For March 14, 2024 March 14, 2024 Via Benzinga Eton Pharmaceuticals Awarded U.S. Patent for Proprietary Hydrocortisone Oral Liquid Formulation February 21, 2024 From Eton Pharmaceuticals Via GlobeNewswire Eton Pharmaceuticals Announces Commercial Availability of Ultra-Rare Disease Product Nitisinone Capsules February 02, 2024 From Eton Pharmaceuticals Via GlobeNewswire Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
